| Neurofibromatosis type 1: a multidisciplinary approach to care AC Hirbe, DH Gutmann The Lancet Neurology 13 (8), 834-843, 2014 | 679 | 2014 |
| RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation S Vaira, T Johnson, AC Hirbe, M Alhawagri, I Anwisye, B Sammut, ... Proceedings of the National Academy of Sciences 105 (10), 3897-3902, 2008 | 192 | 2008 |
| Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas M Pekmezci, DE Reuss, AC Hirbe, S Dahiya, DH Gutmann, ... Modern Pathology 28 (2), 187-200, 2015 | 172 | 2015 |
| Skeletal complications of breast cancer therapies A Hirbe, EA Morgan, O Uluçkan, K Weilbaecher Clinical Cancer Research 12 (20), 6309s-6314s, 2006 | 121 | 2006 |
| Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner AC Hirbe, O Uluçkan, EA Morgan, MC Eagleton, JL Prior, ... Blood 109 (8), 3424-3431, 2007 | 110 | 2007 |
| The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling X Su, DH Floyd, A Hughes, J Xiang, JG Schneider, O Uluckan, E Heller, ... The Journal of clinical investigation 122 (10), 3579-3592, 2012 | 106 | 2012 |
| Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review PJ Oppelt, AC Hirbe, BA Van Tine Journal of gastrointestinal oncology 8 (3), 466, 2017 | 103 | 2017 |
| CD8+ T Cells Regulate Bone Tumor Burden Independent of Osteoclast Resorption K Zhang, S Kim, V Cremasco, AC Hirbe, DV Novack, K Weilbaecher, ... Cancer research 71 (14), 4799-4808, 2011 | 98 | 2011 |
| The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases? AC Hirbe, EA Morgan, KN Weilbaecher Current pharmaceutical design 16 (11), 1284-1290, 2010 | 97 | 2010 |
| The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion DH Gutmann, AC Hirbe, Z Huang, CA Haipek Neurobiology of Disease 8 (2), 266-278, 2001 | 91 | 2001 |
| Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives BC Prudner, T Ball, R Rathore, AC Hirbe Neuro-Oncology Advances 2 (Supplement_1), i40-i49, 2020 | 89 | 2020 |
| Developmental regulation of a neuron‐specific neurofibromatosis 1 isoform DH Gutmann, Y Zhang, A Hirbe Annals of Neurology: Official Journal of the American Neurological …, 1999 | 86 | 1999 |
| HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition L Gao, H Deng, H Zhao, A Hirbe, J Harding, L Ratner, K Weilbaecher Blood 106 (13), 4294-4302, 2005 | 82 | 2005 |
| The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts AC Hirbe, AJ Roelofs, DH Floyd, H Deng, SN Becker, LG Lanigan, ... Bone 44 (5), 908-916, 2009 | 78 | 2009 |
| APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice Ö Uluçkan, MC Eagleton, DH Floyd, EA Morgan, AC Hirbe, M Kramer, ... Journal of cellular biochemistry 104 (4), 1311-1323, 2008 | 68 | 2008 |
| Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone AC Hirbe, J Rubin, Ö Uluçkan, EA Morgan, MC Eagleton, JL Prior, ... Proceedings of the National Academy of Sciences 104 (35), 14062-14067, 2007 | 67 | 2007 |
| Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study JJ Szymanski, RT Sundby, PA Jones, D Srihari, N Earland, PK Harris, ... PLoS Medicine 18 (8), e1003734, 2021 | 65 | 2021 |
| Functional analysis of neurofibromatosis 2 (NF2) missense mutations DH Gutmann, AC Hirbe, CA Haipek Human molecular genetics 10 (14), 1519-1529, 2001 | 65 | 2001 |
| A Non-Tumor Suppressor Role for Basal p19ARF in Maintaining Nucleolar Structure and Function AJ Apicelli, LB Maggi Jr, AC Hirbe, AP Miceli, ME Olanich, ... Molecular and cellular biology 28 (3), 1068-1080, 2008 | 63 | 2008 |
| Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases JSA Chrisinger, B Wehrli, BC Dickson, S Fasih, AC Hirbe, DB Shultz, ... Virchows Archiv 477, 725-732, 2020 | 59 | 2020 |
